Project Title: Utility Steam Generation Plant Design
Project Summary: Lotte Biologics is a South Korean Contract Development and Manufacturing Organization (CDMO). Lotte Biologics specializes in manufacturing large quantities of biologics medicines, which are typically related to the immune system and are delivered via IV or syringe. Once manufactured, these medicines are distributed to large pharmaceutical companies for sale. In 2020, Lotte Biologics purchased a manufacturing plant from Bristol-Myers Squibb in Syracuse, NY, making the facility the only U.S. manufacturing plant owned by the company. Currently, the facility is outfitted with a 3 – 800 bhp boiler steam plant. It acts as a heat source for the HVAC systems on campus, providing comfort heating during the cold winter months.In addition, the steam plant is a crucial process utility, supplying steam required to sterilize bioreactors and water used in IV bags. While serving a crucial role in the facility’s operation, the current plant is 80 years old, and significantly oversized for its current purpose. Both factors cause significant operational inefficiencies and lead the plant to draw more power and produce additional emissions. Our group has been tasked with the development of an appropriately sized new design, which meets current and future facility demands in a highly efficient manner. Furthermore, there is a strong emphasis on highly innovative and sustainable design, leading the client to serve as an example of environmentally conscious industry in the State of New York.
